regulatory agencies

Prescription drugs: state monitoring programs may help to reduce illegal diversion

Publication Date: 

2002

Read report
Tags: case investigation, Controlled Substances Act, diversion, government reports, PDMP impact, PMP data, PMP operations, regulatory agencies, state comparisons, testimony

Maximizing the value of electronic prescription monitoring programs

Author: 

Brushwood, David B.

Publication Date: 

2003

Publication: 
Journal of Law, Medicine and Ethics; 31(1):41-54.
Read article
Tags: access to treatment, ARCOS, balancing patient care and drug control, best practices, chilling effect, diversion, epidemiology, evaluations, journal articles, pain management, PDMP impact, PMP data, PMP operations, prescribing practices, privacy concerns, regulatory agencies, unintended consequences

Pain management and prescription monitoring

Author: 

Joranson, D.E., Carrow, G.M., Ryan, K.M., Schaefer, L., Gilson, A.M., Good, P., Eadie, J., Peine, S., Dahl, J.L.

Publication Date: 

2002

Publication: 
Journal of Pain and Symptom Management. 23(3):231-8.
Read abstract and full article.
Tags: balancing patient care and drug control, journal articles, pain management, PDMP impact, PMP operations, regulatory agencies, state comparisons, triplicate prescriptions, undertreatment of pain, unintended consequences

HOME | ABOUT | THE PROBLEM | CLEARINGHOUSE | NEWS | WORK | PERFORMANCE | CONTACT | SITE MAP |
© 2010-2013 Brandeis University, PDMP Center of Excellence. All Rights Reserved.
The COE is a joint project of the Institute of Behavioral Health at Brandeis University, and the Bureau of Justice Assistance.

BJA Logo